VANCOUVER, B.C. — ME Therapeutics Holdings Inc , a publicly listed biotechnology company working on novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer, is pleased… Read More
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen as a new… Read More
Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry population The company is finalizing… Read More
Study Opens Door to Sustainable Path for Polystyrene Petri Dishes, PET Tubes, Medical Tubing, and Polypropylene Syringes Across Healthcare Supply Chains FRANKLIN LAKES, N.J. and BIRDHILL, Colo. and TIPPERARY, Ireland – BD… Read More
UBC researchers have engineered gut bacteria that dim their fluorescent glow in the presence of illness. Their findings, published in Cell, could improve how we diagnose problems in the gut by… Read More
